Concepedia

Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotides

P. M. A. B. Terheggen, B.G.J. Floot, E. L. M. Lempers, Olaf van Tellingen, Adrian C. Begg, L. Den Engelse

Cancer Chemotherapy and Pharmacology · 1991 · 27 citations · 31 references

DOI

Concepts

References

31

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

Anne Marie J. Fichtinger-Schepman, J. L. VAN DER VEER, Jeroen H. J. Den Hartog et al. · Biochemistry · 1985 · 1K citations

, , +8

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

Richard J. Knox, Frank Friedlos, David Lydall et al. · PubMed · 1986 · 499 citations

, , +15

Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA

Alan Eastman · Biochemistry · 1986 · 458 citations

, , +7

A New Mouse Tumor Model System (RIF-1) for Comparison of End-Point Studies<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

P R Twentyman, J. Martin Brown, Joe W. Gray et al. · JNCI Journal of the National Cancer Institute · 1980 · 379 citations

, , +17

New Chemistry of an Old Molecule: <i>cis</i> -[Pt(NH <sub>3</sub> ) <sub>2</sub> Cl <sub>2</sub> ]

Stephen J. Lippard · Science · 1982 · 307 citations

, , +9